Marimed Valuation

MRMD Stock  USD 0.14  0.01  6.67%   
Marimed seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Marimed from analyzing the firm fundamentals such as Current Valuation of 178.51 M, profit margin of 0.02 %, and Return On Equity of 0.0303 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors recommend purchasing undervalued stocks and exiting overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
0.14
Please note that Marimed's price fluctuation is out of control at this time. Calculation of the real value of Marimed is based on 3 months time horizon. Increasing Marimed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Marimed otc stock is determined by what a typical buyer is willing to pay for full or partial control of Marimed. Since Marimed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Marimed OTC Stock. However, Marimed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.14 Real  0.13 Hype  0.14 Naive  0.14
The real value of Marimed OTC Stock, also known as its intrinsic value, is the underlying worth of Marimed OTC Stock, which is reflected in its stock price. It is based on Marimed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Marimed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.13
Real Value
5.28
Upside
Estimating the potential upside or downside of Marimed helps investors to forecast how Marimed otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Marimed more accurately as focusing exclusively on Marimed's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.140.150.16
Details
Hype
Prediction
LowEstimatedHigh
0.010.145.29
Details
Naive
Forecast
LowNext ValueHigh
00.145.29
Details

Marimed Total Value Analysis

Marimed is now expected to have valuation of 178.51 M with market capitalization of 147.62 M, debt of 448.34 K, and cash on hands of 8.44 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Marimed fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
178.51 M
147.62 M
448.34 K
8.44 M

Marimed Investor Information

About 18.0% of the company outstanding shares are owned by corporate insiders. The book value of Marimed was now reported as 0.16. The company had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Marimed's historical financial statements, Marimed is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.

Marimed Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Marimed has an asset utilization ratio of 98.59 percent. This indicates that the OTC Stock is making $0.99 for each dollar of assets. An increasing asset utilization means that Marimed is more efficient with each dollar of assets it utilizes for everyday operations.

Marimed Ownership Allocation

Marimed maintains a total of 339.35 Million outstanding shares. Marimed secures 17.9 % of its outstanding shares held by insiders and 0.81 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Marimed Profitability Analysis

The company reported the previous year's revenue of 121.46 M. Net Income was 7.22 M with profit before overhead, payroll, taxes, and interest of 66.26 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Marimed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Marimed and how it compares across the competition.

About Marimed Valuation

The otc valuation mechanism determines Marimed's current worth on a weekly basis. Our valuation model uses a comparative analysis of Marimed. We calculate exposure to Marimed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Marimed's related companies.
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts. Marimed operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 260 people.

8 Steps to conduct Marimed's Valuation Analysis

OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Marimed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Marimed's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Marimed's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Marimed's revenue streams: Identify Marimed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Marimed's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Marimed's growth potential: Evaluate Marimed's management, business model, and growth potential.
  • Determine Marimed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Marimed's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the otc stock being valued. We also recomment to seek professional assistance to ensure accuracy.

Marimed Growth Indicators

Investing in growth stocks can be very risky. If the company such as Marimed does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding334 M
Quarterly Earnings Growth Y O Y0.302
Forward Price Earnings23.31
Retained Earnings-97.4 M
Retained Earnings Total Equity-97.4 M

Complementary Tools for Marimed OTC Stock analysis

When running Marimed's price analysis, check to measure Marimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marimed is operating at the current time. Most of Marimed's value examination focuses on studying past and present price action to predict the probability of Marimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marimed's price. Additionally, you may evaluate how the addition of Marimed to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device